Empagliflozin
Also known as Jardiance (us), Gibtulio (india)
An SGLT2 inhibitor for type 2 diabetes and heart / kidney protection.
United States
$336
per month
India
$1
per month
You save
−99.65%save $335/mo · 99.65% cheaper
11.4M US scripts/yr$3.8B potential annual savings$3.8B US spend/yr
Drag to rotate · 3D structureC23H27ClO7
SMILES: C1COC[C@H]1OC2=CC=C(C=C2)CC3=C(C=CC(=C3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)Cl
Compare the price
US price$336per month
India price$5per month
You save$33098% less
Based on 30 tablets per month. US $11.20 vs India $0.18 per tablet.
Total over 1 periodSave $330$336 → $5
The bigger picture
Empagliflozin is filled about 11.4M times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$3.8B
If sourced from India
$13.3M
Potential annual savings
$3.8B
−100%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.